Abstract
Recently, the field of neuroimaging analysis has seen a large number of studies which use machine learning methods to make predictions about the progression of Alzheimer’s Disease (AD) in mildly demented subjects. Among these, Multi-Kernel Learning (MKL) has emerged as a powerful tool for systematically aggregating diverse data views, and several groups have shown that MKL is uniquely suited to combining different imaging modalities into a single learned model. The next phase of this research is to employ these predictive abilities to design more efficient clinical trials. Two issues can hamper a trial’s effectiveness: the presence of non-pathological subjects in a study, and the sensitivity of the chosen outcome measure to the pathology of interest. We offer two approaches for dealing with these issues: trial enrichment, in which MKL-derived predictions are used to screen out subjects unlikely to benefit from a treatment; and custom outcome measures which use an SVM to select a weighted voxel average for use as an outcome measure. We provide preliminary evidence that these two strategies can lead to significant reductions in sample sizes in hypothetical trials, which directly gives reduced costs and higher efficiency in the drug development cycle.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Misra, C., Fan, Y., Davatzikos, C.: Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI. Neuroimage 44(4), 1415–1422 (2008)
Schroeter, M.L., Stein, T., Maslowski, N., Neumann, J.: Neural correlates of alzheimer’s disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 47(4), 1196–1206 (2009)
Davatzikos, C., Xu, F., An, Y., Fan, Y., Resnick, S.M.: Longitudinal progression of Alzheimer’s-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 132(8), 2026–2035 (2009)
Querbes, O., Aubry, F., Pariente, J., Lotterie, J.A., Demonet, J.F., Duret, V., Puel, M., Berry, I., Fort, J.C., Celsis, P.: Early diagnosis of alzheimer’s disease using cortical thickness: impact of cognitive reserve. Brain 132(8), 2036–2047 (2009)
Hinrichs, C., Singh, V., Xu, G., Johnson, S.C.: Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population. Neuroimage 55(2), 574–589 (2011)
Zhang, D., Wang, Y., Zhou, L., Yuan, H., Shen, D.: Multimodal Classification of Alzheimer’s Disease and Mild Cognitive Impairment. NeuroImage 55(3), 856–867 (2011)
Ye, J., Chen, K., Wu, T., Li, J., Zhao, Z., Patel, R., Bae, M., Janardan, R., Liu, H., Alexander, G., et al.: Heterogeneous data fusion for alzheimer’s disease study. In: Proceeding of the 14th ACM SIGKDD, pp. 1025–1033. ACM (2008)
Visser, P.J., Scheltens, P., Verhey, F.R.J.: Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease? Journal of Neurology, Neurosurgery & Psychiatry 76(10), 1348 (2005)
Petersen, R.C., Thomas, R.G., Grundman, M., et al.: Donepezil and vitamin E in the treatment of mild cognitive impairment. N. Engl. J. Med. 352, 2379–2388 (2005)
Kohannim, O., Hua, X., Hibar, D.P., Lee, S., Chou, Y.Y., Toga, A.W., Jack Jr., C.R., Weiner, M.W., Thompson, P.M.: Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiology of Aging 31(8), 1429–1442 (2010)
Hua, X., Lee, S., Yanovsky, I., Leow, A.D., et al.: Optimizing power to track brain degeneration in Alzheimer’s disease and mild cognitive impairment with TBM: An ADNI study of 515 subjects. Neuroimage 48(4), 668–681 (2009)
Cortes, C., Vapnik, V.: Support-vector networks. Machine Learning 20(3), 273–297 (1995)
Sonnenburg, S., Rätsch, G., Schäfer, C., Schölkopf, B.: Large scale multiple kernel learning. Journal of Machine Learning Research 7, 1531–1565 (2006)
Kloft, M., Brefeld, U., Sonnenburg, S., Zien, A.: ℓ p -Norm Multiple Kernel Learning. JMLR 12, 953–997 (2011)
Mueller, S.G., Weiner, M.W., Thal, L.J., Petersen, R.C., et al.: Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association 1(1), 55–66 (2005)
Schott, J.M., Bartlett, J.W., Barnes, J., Leung, K.K., Ourselin, S., Fox, N.C.: Reduced sample sizes for atrophy outcomes in alzheimer’s disease trials: baseline adjustment. Neurobiology of Aging 31(8), 1452–1462 (2010)
Zhang, R.Y., Leon, A.C., Chuang-Stein, C., Romano, S.J.: A new proposal for randomized start design to investigate disease-modifying therapies for Alzheimer disease. Clinical Trials 8(1), 5 (2011)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hinrichs, C., Dowling, N.M., Johnson, S.C., Singh, V. (2012). MKL-Based Sample Enrichment and Customized Outcomes Enable Smaller AD Clinical Trials. In: Langs, G., Rish, I., Grosse-Wentrup, M., Murphy, B. (eds) Machine Learning and Interpretation in Neuroimaging. Lecture Notes in Computer Science(), vol 7263. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34713-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-34713-9_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-34712-2
Online ISBN: 978-3-642-34713-9
eBook Packages: Computer ScienceComputer Science (R0)